Show simple item record

dc.contributor.authorBrady, Thomas J.
dc.contributor.authorKoenig, Wolfgang
dc.contributor.authorKunde, Jan
dc.contributor.authorBergmann, Andreas
dc.contributor.authorDasdemir, Selçuk
dc.contributor.authorHoffmann, Udo
dc.contributor.authorTruong, Quynh A.
dc.contributor.authorSiegel, Emily
dc.contributor.authorKarakas, Mahir
dc.contributor.authorJanuzzi, James L.
dc.contributor.authorBamberg, Fabian
dc.contributor.authorMahabadi, Amir A.
dc.contributor.authorNagurney, John T.
dc.date.accessioned2021-12-10T13:07:55Z
dc.date.available2021-12-10T13:07:55Z
dc.date.issued2010
dc.identifier.citationTruong Q. A. , Siegel E., Karakas M., Januzzi J. L. , Bamberg F., Mahabadi A. A. , Dasdemir S., Brady T. J. , Bergmann A., Kunde J., et al., "Relation of Natriuretic Peptides and Midregional Proadrenomedullin to Cardiac Chamber Volumes by Computed Tomography in Patients without Heart Failure: From the ROMICAT Trial", CLINICAL CHEMISTRY, cilt.56, sa.4, ss.651-660, 2010
dc.identifier.issn0009-9147
dc.identifier.otherav_f02bf457-9cb7-48a3-8edc-657502e40549
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/175467
dc.identifier.urihttps://doi.org/10.1373/clinchem.2009.138586
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/f02bf457-9cb7-48a3-8edc-657502e40549/file
dc.description.abstractBACKGROUND: Stress myocyte biomarkers are used prognostically in patients with cardiovascular disease. We examined associations between amino-terminal pro-B-type natriuretic peptide (NT-proBNP), mid-regional pro-A-type natriuretic peptide (MR-proANP), and midregional proadrenomedullin (MR-proADM) concentrations and cardiac chamber volumes in chest pain patients without heart failure by use of computed tomography (CT).
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectMedical Laboratory Technology
dc.subjectHealth Sciences
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectKlinik Tıp
dc.titleRelation of Natriuretic Peptides and Midregional Proadrenomedullin to Cardiac Chamber Volumes by Computed Tomography in Patients without Heart Failure: From the ROMICAT Trial
dc.typeMakale
dc.relation.journalCLINICAL CHEMISTRY
dc.contributor.departmentHarvard University , ,
dc.identifier.volume56
dc.identifier.issue4
dc.identifier.startpage651
dc.identifier.endpage660
dc.contributor.firstauthorID2645338


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record